​

CDT Equity Stock (NASDAQ:CDT)

RevenueOwnershipFinancialsChart
CDT Equity by TradingView

Previous Close

$3.10

52W Range

$2.72 - $2.20K

50D Avg

$6.96

200D Avg

$109.29

Market Cap

$1.15M

Avg Vol (3M)

$704.93K

Beta

1.78

Div Yield

-

CDT Company Profile

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

6

IPO Date

Mar 28, 2022

Website

CDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24
Automation Solutions$1.32B

Fiscal year ends in Dec 24 | Currency in USD

CDT Financial Summary

Dec 24Dec 23Dec 22
Revenue$2.46B--
Operating Income$266.46M$-5.56M$-3.16M
Net Income$198.43M$-535.00K$-4.89M
EBITDA$266.46M$-324.00K$-1.43M
Basic EPS$4.88$-0.18$-0.56
Diluted EPS$4.80$-0.18$-0.56

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
ASBPAspire Biopharma Holdings, Inc.
SCNIScinai Immunotherapeutics Ltd.
ZVSAZyVersa Therapeutics, Inc.
SPRCSciSparc Ltd.
ADTXAditxt, Inc.
JSPRJasper Therapeutics, Inc.
ONCOOnconetix, Inc.
ENVBEnveric Biosciences, Inc.